{
    "nctId": "NCT00749112",
    "officialTitle": "Low Doses of Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias",
    "inclusionCriteria": "* Age: \\> or = 16 years\n* Weight: more than 40 Kg\n* Autoimmune Hemolytic anemia with clinical and biochemical evidence of hemolysis refractory to treatment, in relapse or steroids dependant\n* Idiopathic thrombocytopenic purpura with platelet counts \\< 50,000, refractory to treatment, in relapse or steroids dependant\n* Must have minimum age of 16 Years",
    "exclusionCriteria": "* Current viral or bacterial infection.\n* Positive serology for HIV, HCV, HBV."
}